Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours Data presented at 2026 ASCO Annual Meeting show ODM-212 was well tolerated, with proteinuria being the most common…
D-Wave Quantum Still Lags Behind The Industry Average, Hold For Now (NYSE:QBTS)
D-Wave Quantum Inc. underperforms peers on return and volatility metrics and remains more unpredictable than other pure-play quantum companies, but investor pessimism is exaggerated. Recent revenue declines were expected due to prior one-time…
Copa: An Airline With Strong Q1 Results Despite Sector Headwinds (NYSE:CPA)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
BMO Beats Quarterly Earnings Again, And Remains A Strong Dividend Idea Among Banks (BMO)
Bank of Montreal (BMO) remains a buy, supported by robust segment growth, dividend strength, and a conservative balance sheet, despite a rich valuation. BMO's Q2 saw YoY revenue growth across all business lines, with wealth and capital markets as…
Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors
The big news in the GLP-1 weight loss drug space right now is the introduction of pills. That seems to have broadened the appeal of GLP-1s, as many consumers simply don't like to take shots. Eli Lilly (LLY 1.87%) just introduced its own pill…
Thriving in the Age of Overwhelm
How can you separate market signal from media noise when headlines are designed to hijack your attention? In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributor Rachel Warren talks with Fred Marshall, author of Thrive: The…
Intech Investment Management LLC Has $12.49 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
Intech Investment Management LLC lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange…
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?
With a market cap of $149.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines across a wide range of therapeutic areas in the United States and…
Pluralistic: Carneyism without Carney (30 May 2026)
Carneyism without Carney: Eh? Hey look at this: Delights to delectate. Object permanence: Replacing pharma patents with bounties; USTR v cheap leukemia meds; Plutocrats x wealth segregation; Anonymous Analytics; Scott Walker sells off donors;…
Eurizon Capital SGR S.p.A. Makes New $35.09 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX
Eurizon Capital SGR S.p.A. acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
Fisher Asset Management LLC Invests $933,000 in Krystal Biotech, Inc. $KRYS
Fisher Asset Management LLC acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm…
Eurizon Capital SGR S.p.A. Acquires New Stake in Pfizer Inc. $PFE
Eurizon Capital SGR S.p.A. acquired a new stake in Pfizer Inc. (NYSE:PFE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired…
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 2,929 Shares of The Goldman Sachs Group, Inc. $GS
Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its stake in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 4.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange…
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Cuts Stock Position in AbbVie Inc. $ABBV
Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned…
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Intech Investment Management LLC
Intech Investment Management LLC decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 17.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm…
Receive a Daily briefing on Pharma Industry News
Get Started